Our correlation analysis revealed that EGFR expression was strongly correlated with expressions of mTOR (r= 0.262–0.496) and FGFR1 (r= 0.203–0.348) in liver, lung, kidney, glioblastoma, colon, head and neck, and breast cancers. Here, MTOR is linked to breast carcinoma.